FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080104927> ?p ?o ?g. }

• W3080104927 endingPage "82" @default.
• W3080104927 startingPage "82" @default.
• W3080104927 abstract "The global pandemic caused by SARS-CoV-2 virus has challenged public health system worldwide due to the unavailability of approved preventive and therapeutic options. Identification of neutralizing antibodies (NAb) and understanding their role is important. However, the data on kinetics of NAb response among COVID-19 patients are unclear. To understand the NAb response in COVID-19 patients, we compared the findings of microneutralization test (MNT) and plaque reduction neutralization test (PRNT) for the SARS-CoV-2. Further, the kinetics of NAb response among COVID-19 patients was assessed.A total of 343 blood samples (89 positive, 58 negative for SARS-CoV-2 and 17 cross-reactive and 179 serum from healthy individuals) were collected and tested by MNT and PRNT. SARS-CoV-2 virus was prepared by propagating the virus in Vero CCL-81 cells. The intra-class correlation was calculated to assess the correlation between MNT and PRNT. The neutralizing endpoint as the reduction in the number of plaque count by 90 per cent (PRNT90) was also calculated.The analysis of MNT and PRNT quantitative results indicated that the intra-class correlation was 0.520. Of the 89 confirmed COVID-19 patients, 64 (71.9%) showed NAb response.The results of MNT and PRNT were specific with no cross-reactivity. In the early stages of infection, the NAb response was observed with variable antibody kinetics. The neutralization assays can be used for titration of NAb in recovered/vaccinated or infected COVID-19 patients." @default.
• W3080104927 created "2020-09-01" @default.
• W3080104927 creator A5009304672 @default.
• W3080104927 creator A5010095366 @default.
• W3080104927 creator A5011608811 @default.
• W3080104927 creator A5012949795 @default.
• W3080104927 creator A5013420798 @default.
• W3080104927 creator A5017243285 @default.
• W3080104927 creator A5017691573 @default.
• W3080104927 creator A5018332408 @default.
• W3080104927 creator A5044157577 @default.
• W3080104927 creator A5052281926 @default.
• W3080104927 creator A5060094900 @default.
• W3080104927 creator A5072050337 @default.
• W3080104927 creator A5072386421 @default.
• W3080104927 creator A5076835559 @default.
• W3080104927 creator A5079460809 @default.
• W3080104927 creator A5084980428 @default.
• W3080104927 creator A5091465479 @default.
• W3080104927 date "2020-01-01" @default.
• W3080104927 modified "2023-10-16" @default.
• W3080104927 title "Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients" @default.
• W3080104927 cites W2614315918 @default.
• W3080104927 cites W2911386255 @default.
• W3080104927 cites W2989173305 @default.
• W3080104927 cites W3008028633 @default.
• W3080104927 cites W3012846954 @default.
• W3080104927 cites W3014095365 @default.
• W3080104927 cites W3017195969 @default.
• W3080104927 cites W3017962953 @default.
• W3080104927 cites W3021590963 @default.
• W3080104927 cites W3025337462 @default.
• W3080104927 cites W3033861170 @default.
• W3080104927 cites W3036931136 @default.
• W3080104927 cites W3038553353 @default.
• W3080104927 doi "https://doi.org/10.4103/ijmr.ijmr_2382_20" @default.
• W3080104927 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7853248" @default.
• W3080104927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32859866" @default.
• W3080104927 hasPublicationYear "2020" @default.
• W3080104927 type Work @default.
• W3080104927 sameAs 3080104927 @default.
• W3080104927 citedByCount "62" @default.
• W3080104927 countsByYear W30801049272020 @default.
• W3080104927 countsByYear W30801049272021 @default.
• W3080104927 countsByYear W30801049272022 @default.
• W3080104927 countsByYear W30801049272023 @default.
• W3080104927 crossrefType "journal-article" @default.
• W3080104927 hasAuthorship W3080104927A5009304672 @default.
• W3080104927 hasAuthorship W3080104927A5010095366 @default.
• W3080104927 hasAuthorship W3080104927A5011608811 @default.
• W3080104927 hasAuthorship W3080104927A5012949795 @default.
• W3080104927 hasAuthorship W3080104927A5013420798 @default.
• W3080104927 hasAuthorship W3080104927A5017243285 @default.
• W3080104927 hasAuthorship W3080104927A5017691573 @default.
• W3080104927 hasAuthorship W3080104927A5018332408 @default.
• W3080104927 hasAuthorship W3080104927A5044157577 @default.
• W3080104927 hasAuthorship W3080104927A5052281926 @default.
• W3080104927 hasAuthorship W3080104927A5060094900 @default.
• W3080104927 hasAuthorship W3080104927A5072050337 @default.
• W3080104927 hasAuthorship W3080104927A5072386421 @default.
• W3080104927 hasAuthorship W3080104927A5076835559 @default.
• W3080104927 hasAuthorship W3080104927A5079460809 @default.
• W3080104927 hasAuthorship W3080104927A5084980428 @default.
• W3080104927 hasAuthorship W3080104927A5091465479 @default.
• W3080104927 hasBestOaLocation W30801049271 @default.
• W3080104927 hasConcept C126322002 @default.
• W3080104927 hasConcept C138894074 @default.
• W3080104927 hasConcept C159047783 @default.
• W3080104927 hasConcept C159654299 @default.
• W3080104927 hasConcept C203014093 @default.
• W3080104927 hasConcept C2522874641 @default.
• W3080104927 hasConcept C2779134260 @default.
• W3080104927 hasConcept C2779261636 @default.
• W3080104927 hasConcept C3007834351 @default.
• W3080104927 hasConcept C3008058167 @default.
• W3080104927 hasConcept C524204448 @default.
• W3080104927 hasConcept C71924100 @default.
• W3080104927 hasConceptScore W3080104927C126322002 @default.
• W3080104927 hasConceptScore W3080104927C138894074 @default.
• W3080104927 hasConceptScore W3080104927C159047783 @default.
• W3080104927 hasConceptScore W3080104927C159654299 @default.
• W3080104927 hasConceptScore W3080104927C203014093 @default.
• W3080104927 hasConceptScore W3080104927C2522874641 @default.
• W3080104927 hasConceptScore W3080104927C2779134260 @default.
• W3080104927 hasConceptScore W3080104927C2779261636 @default.
• W3080104927 hasConceptScore W3080104927C3007834351 @default.
• W3080104927 hasConceptScore W3080104927C3008058167 @default.
• W3080104927 hasConceptScore W3080104927C524204448 @default.
• W3080104927 hasConceptScore W3080104927C71924100 @default.
• W3080104927 hasIssue "1" @default.
• W3080104927 hasLocation W30801049271 @default.
• W3080104927 hasLocation W30801049272 @default.
• W3080104927 hasLocation W30801049273 @default.
• W3080104927 hasOpenAccess W3080104927 @default.
• W3080104927 hasPrimaryLocation W30801049271 @default.
• W3080104927 hasRelatedWork W1550873968 @default.
• W3080104927 hasRelatedWork W1693544388 @default.
• W3080104927 hasRelatedWork W2003425895 @default.

• next